MedPath

ROZLYTREK 50 MG GRANULADO RECUBIERTO CON PELICULA EN SOBRE

ROZLYTREK 50 MG GRANULADO RECUBIERTO CON PELICULA EN SOBRE

Pending
Register Number

1201460003

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Aug 16, 2024

Dosage Form

GRANULADO RECUBIERTO

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1201460003
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (1)

ENTRECTINIBActive
Quantity: 50 mg
Name: ENTRECTINIB

ATC CLASSIFICATION (3)

L01E
L01EX
L01EX14

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.